Clinical phenotype of LRRK2R1441C in 2 Chinese sisters
Pathogenic and risk variants in theLRRK2gene are among the main genetic contributors to Parkinson's disease (PD) worldwide, and LRRK2-targeted therapies for patients with PARK-LRRK2are now entering clinical trials. However, in contrast to theLRRK2G2019S mutation commonly found in Caucasians, No...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Karger
2020
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/31664/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|